Memorial Sloan-Kettering Cancer Center
researchers have found that colorectal cancer patients with cancer metastasized to the liver, lived longer and enjoyed
a better quality of life, if they received chemotherapy directly to the liver through a
pump in the abdomen, instead of standard intravenous chemotherapy. Researchers find the conclusions of this study
hopeful for colorectal cancer patients, because statistically, 60 percent of the time, colorectal cancer will spread to
the liver. During the study, it was noted that colorectal cancer patients who were treated with the hepatic arterial
infusion therapy, HAI, did not suffer the usual chemotherapy side-effects that patients treated with standard
chemotherapy suffer.Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
New chemo treatment to liver for colorectal cancer
Memorial Sloan-Kettering Cancer Center
researchers have found that colorectal cancer patients with cancer metastasized to the liver, lived longer and enjoyed
a better quality of life, if they received chemotherapy directly to the liver through a
pump in the abdomen, instead of standard intravenous chemotherapy. Researchers find the conclusions of this study
hopeful for colorectal cancer patients, because statistically, 60 percent of the time, colorectal cancer will spread to
the liver. During the study, it was noted that colorectal cancer patients who were treated with the hepatic arterial
infusion therapy, HAI, did not suffer the usual chemotherapy side-effects that patients treated with standard
chemotherapy suffer.
